首页> 外文OA文献 >Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies
【2h】

Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies

机译:乳腺癌的多药耐药性:从体外模型到临床研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of multidrug resistance (MDR) and subsequent relapse on therapy is a widespread problem in breast cancer, but our understanding of the underlying molecular mechanisms is incomplete. Numerous studies have aimed to establish the role of drug transporter pumps in MDR and to link their expression to response to chemotherapy. The ATP-binding cassette (ABC) transporters are central to breast cancer MDR, and increases in ABC expression levels have been shown to correlate with decreases in response to various chemotherapy drugs and a reduction in overall survival. But as there is a large degree of redundancy between different ABC transporters, this correlation has not been seen in all studies. This paper provides an introduction to the key molecules associated with breast cancer MDR and summarises evidence of their potential roles reported from model systems and clinical studies. We provide possible explanations for why despite several decades of research, the precise role of ABC transporters in breast cancer MDR remains elusive.
机译:在乳腺癌中,多药耐药性(MDR)的发展和随后的治疗复发是一个普遍存在的问题,但我们对潜在分子机制的理解尚不完善。许多研究旨在确定药物转运泵在MDR中的作用,并将其表达与对化学疗法的反应联系起来。 ATP结合盒(ABC)转运蛋白是乳腺癌MDR的关键,并且已证明ABC表达水平的提高与对各种化学疗法药物的反应降低以及总生存期降低相关。但是,由于不同的ABC转运蛋白之间存在很大程度的冗余,因此并未在所有研究中都看到这种相关性。本文介绍了与乳腺癌MDR相关的关键分子,并总结了模型系统和临床研究报告的潜在分子作用的证据。我们提供了可能的解释,说明为什么尽管进行了数十年的研究,但ABC转运蛋白在乳腺癌MDR中的确切作用仍然难以捉摸。

著录项

  • 作者

    Wind, N. S.; Holen, I.;

  • 作者单位
  • 年度 2011
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号